AstraZeneca/Cellartis To Use Human Embryonic Stem Cells For Predictive Toxicology
U.K. firm looks to increase safety, avoid expensive late-stage failures with preclinical screening on real human liver and heart muscle tissue.
U.K. firm looks to increase safety, avoid expensive late-stage failures with preclinical screening on real human liver and heart muscle tissue.